🔎 Trials Near Me

Home › Autoimmune Diseases › Minnesota › Rochester

Autoimmune Diseases clinical trials in Rochester, MN

6 studies for Autoimmune Diseases are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

RecruitingPhase 2/3
  • Mayo Clinic - Accepting Adult Patients, Rochester
Ages 6 to 75 · All sexes · Updated Sep 17, 2026 · NCT06154252

Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy

RecruitingPhase 2
  • Mayo Clinic: Division of Rheumatology, Rochester
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07103746

Abatacept for the Treatment of Giant Cell Arteritis

RecruitingPhase 3
  • Mayo Clinic, Rochester
Ages 50 and older · All sexes · Updated Aug 20, 2026 · NCT04474847

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

RecruitingPhase 2/3
  • Mayo Clinic Rochester, Rochester
Ages 18 to 75 · All sexes · Updated Aug 17, 2026 · NCT06328777

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

RecruitingPhase 1/2
  • Mayo Clinic - Rochester, Rochester
Ages 18 to 70 · All sexes · Updated Aug 13, 2026 · NCT06359041

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

RecruitingPhase 1
  • Mayo Clinic, Rochester
Ages 18 and older · All sexes · Updated Feb 25, 2026 · NCT06626919

About Autoimmune Diseases

Autoimmune diseases are where your immune system attacks healthy cells in your body by mistake. Learn about the symptoms, tests, and treatments.

More about Autoimmune Diseases on MedlinePlus

Autoimmune Diseases trials in other cities

Other studies in Rochester

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.